Clinical Development PhysicianSanofiSwiftwater, Pennsylvania, United States
Disclosure(s): Sanofi: Employee, Stocks/Bonds (Public Company)
221 - Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) when Co-administered with Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US and Puerto Rico
Thursday, October 17, 20244:00 PM – 4:15 PM US PT